Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...

This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.

A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...

As rheumatologists prepare for EULAR 2026, Clinical Trials Arena takes a look at the most promising drugs in late-stage development for PsA.

Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...

Dragonfly Therapeutics, a clinical-stage biopharmaceutical company pioneering novel immunotherapies, today announced that the first patients have been successfully dosed subcutaneously (SC) with its ...

Adam Thomas clashed with two campmates in the I’m A Celebrity jungle (Picture: Shutterstock) I’m A Celebrity… Get Me Out of ...

Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults ...

TREMFYA's market opportunities lie in its strong clinical efficacy, disease-modifying potential, and favorable safety profile across psoriasis and psoriatic arthritis. With broad label expansion into ...

Celebrities may have glam squads and access to the best doctors and treatments in the world — and yet even they have skin ...

Millions of people living with arthritis may unknowingly be eating foods that increase inflammation, joint stiffness, and ...

Introduction: The introduction of biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) has improved healthcare and health outcomes in patients with rheumatic ...